Trials / Conditions / Juvenile Myelomonocytic Leukemia (JMML)

Juvenile Myelomonocytic Leukemia (JMML)

7 registered clinical trials studyying Juvenile Myelomonocytic Leukemia (JMML).

Status	Trial	Sponsor	Phase
Active Not Recruiting	TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in NCT03849651	St. Jude Children's Research Hospital	Phase 2
Active Not Recruiting	Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haplo NCT02790515	St. Jude Children's Research Hospital	Phase 2
Terminated	Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation NCT02259348	St. Jude Children's Research Hospital	Phase 2
Active Not Recruiting	CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant NCT02061800	Diane George	Phase 1 / Phase 2
Completed	Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Mali NCT00566696	St. Jude Children's Research Hospital	Phase 2
Completed	Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies NCT00145613	St. Jude Children's Research Hospital	Phase 2
Completed	Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies NCT00186823	St. Jude Children's Research Hospital	Phase 3